Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp204036 ◽

2021 ◽

Author(s):

Yoon-Kyoung Sung ◽

Young Ho Lee

Keyword(s):

Tumor Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Biologic Agents ◽

Controlled Trials ◽

Inadequate Response ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Necrosis Factor

Download Full-text

Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials

Clinical Rheumatology ◽

10.1007/s10067-019-04595-1 ◽

2019 ◽

Vol 38 (10) ◽

pp. 2765-2776 ◽

Cited By ~ 6

Author(s):

Yanrong Huang ◽

Yong Fan ◽

Yang Liu ◽

Wenhui Xie ◽

Zhuoli Zhang

Keyword(s):

Tumor Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Phase Iii ◽

Controlled Trials ◽

Inadequate Response ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Necrosis Factor

Download Full-text

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12822 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1103-1111 ◽

Cited By ~ 15

Author(s):

Young Ho Lee ◽

Sang-Cheol Bae

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Necrosis Factor

Download Full-text

Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease‑modifying anti‑rheumatic drugs: A meta‑analysis of randomized controlled trials

Experimental and Therapeutic Medicine ◽

10.3892/etm.2018.6495 ◽

2018 ◽

Cited By ~ 2

Author(s):

Zhi‑Peng Wu ◽

Pei Zhang ◽

Jian‑Zhong Bai ◽

Yuan Liang ◽

Jin‑Shan He ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Inadequate Response ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Disease Modifying

Download Full-text

Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Clinical Rheumatology ◽

10.1007/s10067-018-4002-9 ◽

2018 ◽

Vol 37 (5) ◽

pp. 1199-1205

Author(s):

Sang-Cheol Bae ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

THU0213 Comparative efficacy and safety of baricitinib 2 MG and 4 MG in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials

10.1136/annrheumdis-2017-eular.1245 ◽

2017 ◽

Author(s):

YH Lee ◽

YH Seo ◽

GG Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Clinical Drug Investigation ◽

10.1007/s40261-019-00863-9 ◽

2019 ◽

Vol 40 (1) ◽

pp. 65-72 ◽

Cited By ~ 1

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp203635 ◽

2020 ◽

Vol 58 (06) ◽

pp. 293-298

Author(s):

Gwan Gyu Song ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Zeitschrift für Rheumatologie ◽

10.1007/s00393-019-0601-3 ◽

2019 ◽

Vol 79 (1) ◽

pp. 103-111

Author(s):

G. G. Song ◽

Y. H. Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Efficacy and safety of tumor necrosis factor-α blockers for ulcerative colitis: A systematic review and meta-analysis of published randomized controlled trials

Journal of Food and Drug Analysis ◽

10.1016/j.jfda.2014.06.003 ◽

2015 ◽

Vol 23 (1) ◽

pp. 1-10 ◽

Cited By ~ 4

Author(s):

Yun-Na Song ◽

Ping Zheng

Keyword(s):

Systematic Review ◽

Ulcerative Colitis ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials

The Korean Journal of Internal Medicine ◽

10.3904/kjim.2014.29.5.656 ◽

2014 ◽

Vol 29 (5) ◽

pp. 656 ◽

Cited By ~ 21

Author(s):

Gwan Gyu Song ◽

Sang-Cheol Bae ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Inadequate Response ◽

Efficacy And Safety ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Randomized Controlled ◽

Disease Modifying

Download Full-text

Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials

Efficacy and safety of secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease‑modifying anti‑rheumatic drugs: A meta‑analysis of randomized controlled trials

Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

THU0213 Comparative efficacy and safety of baricitinib 2 MG and 4 MG in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials

Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Efficacy and safety of tumor necrosis factor-α blockers for ulcerative colitis: A systematic review and meta-analysis of published randomized controlled trials

Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials